Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
NYXH
#5460
Nyxoah SA Ordinary Shares
4.0
8
-8.11%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-8.11%
Variazione Mensile
-13.74%
Variazione di 6 mesi
-33.66%
Variazione Annuale
-58.91%
Chiusura Precedente
4.4
4
Open
3.9
7
Bid
Ask
Low
3.9
4
High
4.1
1
Volume
67
Mercati
Mercato Azionario Statunitense
Salute
NYXH
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
37.43 M
117.72 M
Valuation ratios
Enterprise value
299.42 M
1.16 B
Price to earnings ratio
—
—
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
—
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
—
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
—
—
Net current asset value per share
—
—
Tangible book value per share
—
—
Working capital per share
—
—
Book value per share
—
—
Notizie
Nyxoah SA (NYXH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Stifel conferma il rating Buy per Nyxoah, mantiene target price a $12
Stifel reiterates Buy rating on Nyxoah stock, maintains $12 price target
Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System
Inspire Medical Systems stock soars after Medicare reimbursement boost
Piper Sandler riduce il target di prezzo delle azioni Nyxoah a $9 da $12
Piper Sandler lowers Nyxoah stock price target to $9 from $12
Nyxoah SA (NYXH) Reports Q3 Loss, Beats Revenue Estimates
Nyxoah ottiene finanziamenti fino a 77 milioni di dollari per la commercializzazione di Genio
Nyxoah secures up to $77 million in financing for Genio commercialization
Disney, Brookfield, Nu Holdings and more set to report earnings Thursday
Nyxoah a Stifel 2025: Crescita strategica e innovazione